Cutaneous T‐cell lymphomas and dupilumab for atopic dermatitis: A systematic review and expert consensus

20260 citationsJournal Articlehybrid Open Access

Authors

Florent Amatore · Inserm

M. Neildez · Inserm

Adèle de Masson · Inserm

Maxime Battistella · Inserm

M. Tauber · Université Claude Bernard Lyon 1

S. Ingen‐Housz‐Oro · Université Paris-Est Créteil

Catherine Droitcourt · Inserm

Abstract

Dupilumab may unmask or exacerbate CTCL, particularly MF and SS. The consensus-based recommendations offer practical guidance for the safe management of patients.

Topics & Keywords

Cutaneous lymphoproliferative disorders research Dermatology and Skin Diseases Lymphoma Diagnosis and Treatment

Publication Details

Published in: Journal of the European Academy of Dermatology and Venereology

DOI: 10.1111/jdv.70407

Field-Weighted Citation Impact: 0.00

Command Palette

Cutaneous T‐cell lymphomas and dupilumab for atopic dermatitis: A systematic review and expert consensus

Authors

Abstract

Topics & Keywords

Publication Details